Lower gastrointestinal symptoms are not predictive of colorectal neoplasia in a faecal occult blood screen-positive population

British Journal of Surgery

Volumn 92, Issue 4, 2005, Pages 478-481

  Ahmed, S ^a   Leslie, A ^a   Thaha, M A ^a   Carey, F A ^a   Steele, R J C ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; ADULT; AGED; ANEMIA; ARTICLE; CANCER SCREENING; COLONOSCOPE; COLORECTAL TUMOR; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE MOTILITY; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; RECTUM HEMORRHAGE; SCREENING TEST; STATISTICAL SIGNIFICANCE; TENESMUS; WEIGHT REDUCTION;

ABDOMINAL PAIN; AGED; ANEMIA; COLONOSCOPY; COLORECTAL NEOPLASMS; DEFECATION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PILOT PROJECTS; RECTAL DISEASES; WEIGHT LOSS;

EID: 17144363217     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4879     Document Type: Article

References (16)

1. Cancer Research Campaign. Cancer Statistics: Large Bowel - UK. CRC: London, 1999.
2. Office of Population Censuses and Surveys. Mortality Statistics by Cause: England and Wales 1992. Series DH2, no. 20. HMSO: London, 1995.
3. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM et al. Reducing mortality from colorectal cancer by screening for faecal occult blood. N Engl J Med 1993; 328: 1365-1371.
4. Hardcastle JD, Chamberlain JO, Robinson MHE, Moss SM, Amar SS, Balfour TW et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-1477.
5. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer by faecal occult blood test. Lancet 1996; 348: 1467-1471.
6. Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C. A systemic review of the effects of screening for colorectal cancer using the faecal occult blood test, Haemoccult. BMJ 1998; 317: 559-565.
7. Thompson MR. ACPGBI referral guidelines for colorectal cancer. Colorectal Dis 2002; 4: 287-297.
8. Thompson MR, Ellis BG, Swarbrick ET, Wood LF, Atkin WS. Identifying and managing patients at low risk of bowel cancer in general practice. BMJ 2003; 327: 263-265.
9. Flashman K, O'Leary DP, Senapati A, Thompson MR. The Department of Health's 'two week standard rule' for bowel cancer: is it working? Gut 2004; 53: 387-391.
10. Steele RJC, Parker R, Patnick J, Warner J, Fraser C, Mowat NAG et al. A demonstration pilot for colorectal cancer screening in the United Kingdom: a new concept in the introduction of healthcare strategies. J Med Screen 2001; 8: 197-207.
11. Steele RJC for the UK Colorectal Cancer Screening Pilot Group. Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ 2004; 329: 133-135.
12. Crossland A, Jones R. Rectal bleeding; prevalence and consultation behaviour. BMJ 1995; 311: 486-488.
13. Thompson JA, Pond CL, Ellis BG, Beach A, Thompson MR. Rectal bleeding in general and hospital practice; 'the tip of the iceberg'. Colorectal Dis 2000; 2: 288-293.
14. Everhart JE, Go VLW, Johannes RS, Fitzsimmons SC, Roth HP, White LR. A longitudinal survey of self-reported bowel habits in the United States. Dig Dis Sci 1989; 34: 1153-1162.
15. Sandler RS. Epidemiology of irritable bowel syndrome in the United States. Gastroenterology 1990; 99: 409-415.
16. Ferraris R, Senore C, Fracchia M, Sciallero S, Bonelli L, Atkin WS et al. Predictive value of rectal bleeding for distal colonic neoplastic lesions in a screened population. Eur J Cancer 2004; 40: 245-252.